> PHENYTOIN and DEXAMETHASONE  In combination with chemotherapeutic medicinal products reduced activity of antiepileptic medicinal products must be anticipated. 
> CIMETIDINE  Concomitant use with CIMETIDINE leads to delayed, major, suspected, increased carmustine toxic effect (due to the  inhibition of carmustine metabolism).  
> DIGOXIN  Concomitant use with DIGOXIN leads to delayed, moderate, suspected, decreased effect of DIGOXIN (due to the decreased DIGOXIN absorption). 
> MELPHALAN  Concomitant use with MELPHALAN leads to increased risk o f pulmonary toxicity. 
